Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Castaigne

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]S Castaigne, H Tilly, F Sigaux, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Oncogene|February 1, 1994
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cellsP Rousselot, B Hardas, A Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderlyH Tilly, S Castaigne, D Bordessoule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemiaP Fenaux, G Tertian, S Castaigne, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patientsC Fermé, E Lepage, P Brice, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Adult T-cell leukemia associated with HTLV1 and positive HIV2 serology in an African woman]J M Miclea, H Baurmann, A Gessain, et al.
Leukemia|June 1, 1991
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acidP H Wiernik, J P Dutcher, E Paietta, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]S Castaigne, H Tilly, F Sigaux, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Oncogene|February 1, 1994
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cellsP Rousselot, B Hardas, A Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderlyH Tilly, S Castaigne, D Bordessoule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemiaP Fenaux, G Tertian, S Castaigne, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patientsC Fermé, E Lepage, P Brice, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Adult T-cell leukemia associated with HTLV1 and positive HIV2 serology in an African woman]J M Miclea, H Baurmann, A Gessain, et al.
Leukemia|June 1, 1991
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acidP H Wiernik, J P Dutcher, E Paietta, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
Pageof 13